View of Low-dose tamoxifen and raloxifene enhance therapeutic effect of ribitol in mouse model of FKRP mutation-related muscular dystrophy

Return to Article Details Low-dose tamoxifen and raloxifene enhance therapeutic effect of ribitol in mouse model of FKRP mutation-related muscular dystrophy Download Download PDF